{
 "awd_id": "9817393",
 "agcy_id": "NSF",
 "tran_type": "Grant",
 "awd_istr_txt": "Continuing Grant",
 "awd_titl_txt": "Regulation of GSK 3B in Xenopus",
 "cfda_num": "47.074",
 "org_code": "08090100",
 "po_phone": null,
 "po_email": "",
 "po_sign_block_name": "Judith Plesset",
 "awd_eff_date": "1999-02-01",
 "awd_exp_date": "2002-01-31",
 "tot_intn_awd_amt": 330000.0,
 "awd_amount": 330000.0,
 "awd_min_amd_letter_date": "1999-01-13",
 "awd_max_amd_letter_date": "2001-03-05",
 "awd_abstract_narration": "Glycogen synthase kinase 3 beta (GSK3b) is an intracellular serine\r\nthreonine kinase found at the heart of a number of important signaling\r\npathways. These include embryonic pattern formation, tumor suppression and\r\nregulation of neurofibrillary tangles in Alzheimer's disease. A dramatic\r\nexample of GSK3 function is in axis formation in the frog Xenopus. Expression\r\nof molecules that act via GSK3b, such as Wnt proteins, or of mutant forms of\r\nGSK3b itself, result in formation of complete ectopic dorsal axes. This\r\nsuggests that reduction in GSK3b activity is sufficient to cause \"dorsalness\".\r\nPreliminary studies indicate that endogenous GSK3b is less abundant on the\r\ndorsal side of the embryo than on the ventral side. This contrasts with the\r\neffects of ectopic Wnt expression in which specific activity of GSK3b is\r\nreduced but abundance is not. This proposal aims to analyze GSK3b regulation\r\nin Xenopus, comparing endogenous mechanisms with classical Wnt regulation, to\r\nbetter understand the modes of regulation of this important protein.\r\n\r\n     Endogenous dorsal depletion of GSK3b ccan only be by reduction of\r\nsynthesis or stability or by translocation of protein away from the dorsal\r\nside. The recently demonstrated role for a GSK3-binding protein suggests a\r\npost-translational mechanism. Therefore, differential stability will be tested\r\nby measuring the half-life of epitope-tagged GSK3b in dorsal versus ventral\r\nlysates. Translocation of pre-existing GSK3b protein will be monitored by\r\nvisualizing localization or dispersion of exogenous, tagged GSK3b versus\r\ncontrol proteins.\r\n\r\n      Sites on the GSK3b protein required for endogenous and Wnt-dependent\r\nregulation are unknown. They will be mapped, exploiting the advantages of the\r\nXenopus system for this purpose. Dorsal-specific and Wnt-dependent protein\r\nmodifications will be coarsely mapped by mass spectrometry of tryptic\r\npeptides. Fine mapping and functional correlation will be done by\r\nsite-directed mutagenesis and expression in vivo. Mutants will be made at\r\ncandidate modification sites and tested in vivo for specific activity with and\r\nwithout expression of Wnts.\r\n\r\n     Preliminary biochemical studies reveal proteins associated with GSK3b in\r\nvivo that do not correspond to known GSK3b-binding proteins. GSK3b-associated\r\nproteins are clearly important and so to identify these novel proteins (and to\r\ndetermine the association or absence of the known proteins in vivo), direct\r\nbiochemical analysis of proteins co-immunoprecipitated with GSK3b will be\r\ncarried out. Gel electrophoresis, Western blotting and microsequencing will be\r\nused.\r\n\r\n\r\n",
 "awd_arra_amount": 0.0,
 "dir_abbr": "BIO",
 "org_dir_long_name": "Directorate for Biological Sciences",
 "div_abbr": "IOS",
 "org_div_long_name": "Division Of Integrative Organismal Systems",
 "awd_agcy_code": "4900",
 "fund_agcy_code": "4900",
 "pi": [
  {
   "pi_role": "Principal Investigator",
   "pi_first_name": "Jeremy",
   "pi_last_name": "Green",
   "pi_mid_init": "B",
   "pi_sufx_name": "",
   "pi_full_name": "Jeremy B Green",
   "pi_email_addr": "Jeremy_Green@dfci.harvard.edu",
   "nsf_id": "000491212",
   "pi_start_date": "1999-01-13",
   "pi_end_date": null
  }
 ],
 "inst": {
  "inst_name": "Dana-Farber Cancer Institute",
  "inst_street_address": "450 BROOKLINE AVE",
  "inst_street_address_2": "",
  "inst_city_name": "BOSTON",
  "inst_state_code": "MA",
  "inst_state_name": "Massachusetts",
  "inst_phone_num": "6176323940",
  "inst_zip_code": "022155418",
  "inst_country_name": "United States",
  "cong_dist_code": "07",
  "st_cong_dist_code": "MA07",
  "org_lgl_bus_name": "DANA-FARBER CANCER INSTITUTE, INC.",
  "org_prnt_uei_num": "",
  "org_uei_num": "DPMGH9MG1X67"
 },
 "perf_inst": {
  "perf_inst_name": "Dana-Farber Cancer Institute",
  "perf_str_addr": "450 BROOKLINE AVE",
  "perf_city_name": "BOSTON",
  "perf_st_code": "MA",
  "perf_st_name": "Massachusetts",
  "perf_zip_code": "022155418",
  "perf_ctry_code": "US",
  "perf_cong_dist": "07",
  "perf_st_cong_dist": "MA07",
  "perf_ctry_name": "",
  "perf_ctry_flag": "1"
 },
 "pgm_ele": [
  {
   "pgm_ele_code": "111900",
   "pgm_ele_name": "Animal Developmental Mechanism"
  }
 ],
 "pgm_ref": [
  {
   "pgm_ref_code": "9183",
   "pgm_ref_txt": "GENERAL FOUNDATIONS OF BIOTECHNOLOGY"
  },
  {
   "pgm_ref_code": "BIOT",
   "pgm_ref_txt": "BIOTECHNOLOGY"
  }
 ],
 "app_fund": [
  {
   "app_code": "0100",
   "app_name": "NSF RESEARCH & RELATED ACTIVIT",
   "app_symb_id": "490100",
   "fund_code": "app-0100",
   "fund_name": "",
   "fund_symb_id": ""
  },
  {
   "app_code": "0101",
   "app_name": "NSF RESEARCH & RELATED ACTIVIT",
   "app_symb_id": "040100",
   "fund_code": "01000102DB",
   "fund_name": "NSF RESEARCH & RELATED ACTIVIT",
   "fund_symb_id": "040100"
  },
  {
   "app_code": "0199",
   "app_name": "NSF RESEARCH & RELATED ACTIVIT",
   "app_symb_id": "490100",
   "fund_code": "app-0199",
   "fund_name": "",
   "fund_symb_id": ""
  }
 ],
 "oblg_fy": [
  {
   "fund_oblg_fiscal_yr": 1999,
   "fund_oblg_amt": 110000.0
  },
  {
   "fund_oblg_fiscal_yr": 2000,
   "fund_oblg_amt": 110000.0
  },
  {
   "fund_oblg_fiscal_yr": 2001,
   "fund_oblg_amt": 110000.0
  }
 ],
 "por": null
}